Search
for
Sort by
Research 31–60 of 1000+
- Ophiasis Alopecia Areata in a Patient With Spondyloarthritis on Secukinumab: A Case Report and Review of the Literature
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study
- 269 Down-regulatory role of cholecystokinin on psoriatic epidermal inflammation
- Clinical Snippets
- 496 Understanding the mechanism of action of secukinumab using lesional hidradenitis suppurativa skin organ culture
- Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- 128 Bimekizumab led to rapid & deep normalisation of molecular signatures associated with PASI sub-components, preceding clinical skin clearance
- Melatonin Exerts Prominent, Differential Epidermal and Dermal Anti-Aging Properties in Aged Human Eyelid Skin Ex Vivo
- Skin γδ T cell subsets have distinct functions in alopecia areata 3844
- 371 Hair follicles are critical modulators of skin barrier function
- IL-17-producing γδ T cells enhance bone regeneration
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- LB1007 Systemic treatment with a KLK5 inhibitor shows efficacy in a murine model of Netherton syndrome
- LB1667 Successful treatment of rare linear lichen planopilaris with ixekizumab
- Successful treatment of rare linear lichen planopilaris with Ixekizumab
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
- A Novel Role of IL-17+ Cell Subsets in Ross River Virus-Induced Arthritic Disease
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- Bacteria induce skin regeneration via IL-1β signaling
- Editor's Picks August 2023
- Interleukin gene polymorphisms and alopecia areata: A systematic review and meta-analysis
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- γδ T Cells Mediate a Requisite Portion of a Wound Healing Response Triggered by Cutaneous Poxvirus Infection
- Multi-omics revealed that the postbiotic of hawthorn-probiotic alleviated constipation caused by loperamide in elderly mice
- Netherton Syndrome: A Case-Based Review of Diagnosis, Management, and Emerging Treatments.